Dosimetric characterization of 142Pr glass seeds for brachytherapy

Applied Radiation and Isotopes

Volumn 66, Issue 4, 2008, Pages 441-449

  Jung, Jae Won ^a   Reece, Warren Daniel ^a  

^a Department of Electrical and Computer Engineering   (United States)

Author keywords

142Pr; Brachytherapy; Dosimetry; Prostate cancer; Seed

Indexed keywords

BRACHYTHERAPY; PROSTATE CANCER; RADIAL DOSE FUNCTION; REFERENCE DOSE RATE;

ANISOTROPY; MONTE CARLO METHODS; ONCOLOGY;

DOSIMETRY;

GLASS; IODINE 125; PALLADIUM 103; PHOSPHORUS 32; PRASEODYMIUM; PRASEODYMIUM 142; RHENIUM 188; UNCLASSIFIED DRUG; YTTRIUM 90; RADIOISOTOPE;

ANISOTROPY; ARTICLE; BRACHYTHERAPY; CALCULATION; DOSIMETRY; FILM; HUMAN; MALE; MATHEMATICAL COMPUTING; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RADIATION DOSE DISTRIBUTION; RADIOCHROMIC FILM; SCINTISCANNING; CHEMISTRY; COMPUTER ASSISTED RADIOTHERAPY; FILM DOSIMETER; METHODOLOGY; MONTE CARLO METHOD; NEUTRON; PROSTATE TUMOR; RADIATION DOSE;

BRACHYTHERAPY; FILM DOSIMETRY; HUMANS; MALE; MONTE CARLO METHOD; NEUTRONS; PRASEODYMIUM; PROSTATIC NEOPLASMS; RADIOISOTOPES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 39649087124     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2007.11.008     Document Type: Article

References (26)

1. American Cancer Society, 2006. Cancer statistics. 〈http://www.cancer.org/downloads/STT/Cancer_Statistics_2006_Presentation.ppt〉 (accessed 1.10.2006).
2. 90Y source for intravascular brachytherapy by using the Monte Carlo code PENELOPE. Phys. Med. Biol. 47 (2002) 697-711
3. Berger MJ. Distribution of absorbed dose around point sources of electrons and beta particles in water and other media. J. Nucl. Med. Suppl. 5 (1971) 7-23
4. Brenner D.J., and Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 43 (1999) 1095-1101
5. Butson M.J., Cheung T., and Yu P.K. Radiochromic film dosimetry in water phantoms. Phys. Med. Biol. 46 (2001) N27-N31
6. Conzone S.D., Hafeli U.O., and Ehrhardt G.J. Preparation and properties of radioactive rhenium glass microspheres intended for in vivo radioembolization therapy. J. Biomed. Mater. Res. 42 (1998) 617-625
7. Dale R.G. Dose-rate effects in targeted radiotherapy. Phys. Med. Biol. 41 (1996) 1871-1884
8. Dauffy, L., 1998. Calculation of dose to soft tissue from implanted beta sources. A Thesis for Master of Science. Texas A&M University, College Station, Texas.
9. 2 glasses for the in vivo delivery of beta radiation. J. Biomed. Mater. Res. 27 (1993) 1301-1308
10. Jeraj R., Keall P.J., and Ostwald P.M. Comparisons between MCNP, EGS4 and experiment for clinical electron beams. Phys. Med. Biol. 44 (1999) 705-717
11. King C.R., and Fowler J.F. A simple analytic derivation suggests that prostate cancer α/β ratio is low. Int. J. Radiat. Oncol. Biol. Phys. 51 (2001) 213-214
12. Korea Atomic Energy Research Institute, 2006. 〈http://atom.kaeri.re.kr/ton〉 (accessed 1.10.2006).
13. 142Pr microspheres as a potential treatment for arteriovenous malformations. Phys. Med. Biol. 50 (2005) 151-166
14. 32P source Monte Carlo model to derive AAPM TG-60 dosimetric parameters used for intravascular brachytherapy. Med. Phys. 31 (2004) 602-608
15. Nath R., et al. Intravascular brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 60. Med. Phys. 26 (1999) 119-152
16. Reece, W.D., Miller, S.D., Durham, J S., 1989. SADDE (scaled absorbed dose distribution evaluator), a code to generate input for VARSKIN. NUREG/CR-5276. US Nuclear Regulatory Commission, Washington, DC.
17. 125I brachytherapy source. Appl. Radiat. Isot. 57 (2002) 381-389
18. Rivard M.J., et al. Update of AAPM Task Group No. 43 report: a revised AAPM protocol for brachytherapy dose calculations. Med. Phys. 31 (2004) 633-674
19. 90Sr/Y source trains for intravascular brachytherapy. Cardiovasc. Radiat. Med. 3 (2002) 199-204
20. Salem R., Thurston K.G., Carr B.I., Goin J.E., and Geschwind J.H. Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J. Vasc. Intervent. Radiol. 13 (2002) S223-S229
21. Thames H.D., Withers H.R., Peters L.J., and Fletcher G.H. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int. J. Radiat. Oncol. Biol. Phys. 8 (1982) 219-226
22. Traub, R.J., Reece, W.D., Scherpelz, R.I., Sigalla, L.A., 1987. Dose calculation for contamination of the skin using the computer code VARSKIN. NUREG/CR-4418. US Nuclear Regulatory Commission, Washington, DC.
23. Wallner K., Roy J., and Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 32 (1995) 465-471
24. Wei J.T., Dunn R.L., Sandler H.M., McLaughlin P.W., Montie J.E., Litwin M.S., Nyquist L., and Sanda M.G. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin. Oncol. 20 (2002) 557-566
25. White J.E., and Day D.E. Rare earth aluminosilicate glasses for in vivo radiation delivery. Key Eng. Mater. 94-95 (1994) 181-208
26. X-5 Monte Carlo Team, 2003. MCNP-a general Monte Carlo N-particle transport code, Version 5, LA-UR-03-1987.